SomnoMed Limited (ASX:SOM)
Australia · Delayed Price · Currency is AUD 0.4600
-0.0200 (-4.17%)
Jul 17, 2026, 12:01 PM AEST
SomnoMed Market Cap
SomnoMed has a market cap or net worth of 100.78 million as of July 17, 2026. Its market cap has decreased by -28.26% in one year.
Market Cap
100.78M
Enterprise Value
89.36M
Revenue
118.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.46
ChartMarket Cap Chart
Since August 27, 2004, SomnoMed's market cap has increased from 35.20M to 100.78M, an increase of 186.28%. That is a compound annual growth rate of 4.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 100.78M | -40.21% |
| Dec 30, 2025 | 168.55M | 69.55% |
| Dec 27, 2024 | 99.41M | 83.09% |
| Dec 29, 2023 | 54.30M | -49.14% |
| Dec 28, 2022 | 106.76M | -45.11% |
| Dec 31, 2021 | 194.48M | 11.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 282.45M |
| Aroa Biosurgery | 207.54M |
| EMVision Medical Devices | 157.56M |
| Saluda Medical | 134.83M |
| Lumos Diagnostics Holdings | 84.05M |
| Epiminder | 74.64M |
| Cleo Diagnostics | 55.43M |
| OncoSil Medical | 47.43M |